Skip to Main Content

NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

Transforming Biotech in Connecticut

The biotech landscape has been shifting and growing rapidly...

Bioscience

New England Life Science & Biotech Summit

The New England Life Science & Biotech Summit, presented...

Bioscience

Bioscience Policy Debate Shifts at State Legislature

As is always the case, there was much misinformation,...

Bioscience

When Study Becomes the Policy End Game

As complex, controversial legislation churns through the legislative process,...

Bioscience

Connecticut Leads in Anti-Viral R&D

Every member of the Connecticut Bioscience Growth Council was...

Bioscience

Biomarkers and the Path to Medicine 3.O

The Connecticut Bioscience Growth Council and its members—emerging biotechs,...

Bioscience

Insurance Committee Tackles Small Business Healthcare Costs

The legislature’s Insurance and Real Estate Committee acted on...

Bioscience

Committee Considers Net Operating Loss Carry Over Change

A key legislative committee heard testimony March 24 on...

Bioscience

Rare Disease Day 2023

Rare Disease Day Highlights Patient Stories, Policy Needs

Rare Disease Day is an opportunity to heighten awareness...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.